Two distinct forms of the gonocyte, or primitive germ cell, were delimited in the testis of the prepuberal bull. The most primitive of these, the type I gonocyte, gives rise through its mitoses to the type II gonocyte. Type II gonocytes were highly suceptible to the necrotizing effects of ionizing radiation. A dose of 19 rads killed 50% of their number and the residue was all but obliterated by a dose of 38 rads. The${\rm D}_{37}$ for these cells was estimated to be 25 rads. Conversely, the type I gonocyte was highly refractory to irradiation. Some of them survived a dose of 220 rads-a dose lethal to the calf. Gonocytic survival was unaffected by dose rate (0.12-28 rads/min). A dose of 38 rads or more will permanently impair the sperm-producing capacity of bulls irradiated between the 80th day of prenatal life and the 70th day of postnatal life with the magnitude of the effect diminishing as age at irradiation increases. Following exposures sublethal to the bull, increases in both numbers and activity of type I gonocytes plus the appearance of type A spermatogonia in Day 70 postnatal testis are believed to account for the diminution and eventual loss of a permanent testicular effect.
Skip Nav Destination
Close
Article navigation
1 May 1972
Research Article|
May 01 1972
Differentiation and Radioresponse (Dose and Dose Rate) of the Primitive Germ Cell of the Bovine Testis
Radiat Res (1972) 50 (2): 388–400.
Citation
B. H. Erickson, R. A. Reynolds, F. T. Brooks; Differentiation and Radioresponse (Dose and Dose Rate) of the Primitive Germ Cell of the Bovine Testis. Radiat Res 1 May 1972; 50 (2): 388–400. doi: https://doi.org/10.2307/3573497
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner